Compare AVTX & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
Current Price
| Metric | AVTX | IRS |
|---|---|---|
| Founded | 2011 | 1943 |
| Country | United States | Argentina |
| Employees | N/A | 1392 |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 956.7M | 1.1B |
| IPO Year | 2015 | N/A |
| Metric | AVTX | IRS |
|---|---|---|
| Price | $18.82 | $15.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $40.57 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 100.0K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 9.85% |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.66 |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $6.21 | $10.87 |
| 52 Week High | $24.27 | $19.14 |
| Indicator | AVTX | IRS |
|---|---|---|
| Relative Strength Index (RSI) | 55.10 | 49.28 |
| Support Level | $13.13 | $14.76 |
| Resistance Level | $19.06 | $15.96 |
| Average True Range (ATR) | 1.33 | 0.61 |
| MACD | -0.13 | -0.05 |
| Stochastic Oscillator | 48.39 | 40.13 |
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segments include Shopping Malls, which comprise lease and service revenues principally related to the rental of commercial and other spaces in the company's shopping malls; Offices, which include lease revenues and other service revenues related to office activities; Sales and Developments, which include the development, maintenance, and sales of undeveloped parcels of land and/or trading properties; Hotels, which mainly include revenues from rooms, catering, and restaurants; and others. The company generates the majority of its revenue from the Shopping Malls segment.